We have previously performed an immunohistochemical analysis of the expression of CLDN3 and CLDN4 in the Fallopian tubes of 6 patients with serous ovarian cancer and found that both the distal Fallopian tubes and serous ovarian cancers themselves expressed these two proteins in abundance [27]. This evidence concerns the gene CLDN4 and ovarian serous adenocarcinoma.